| ISIN | LU0719899097 |
|---|---|
| Valor Number | 14685997 |
| Bloomberg Global ID | |
| Fund Name | Exane Equity Select Europe Fund B |
| Fund Provider |
Exane Asset Management
75008 Paris |
| Fund Provider | Exane Asset Management |
| Representative in Switzerland |
BNP Paribas, Paris, Zurich Branch Zürich |
| Distributor(s) | CREDIT SUISSE AG |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Luxembourg |
| Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | The Sub-Fund’s investment objective is to outperform its Benchmark Index over the recommended investment horizon. The Sub-Fund is intended for all categories of investors seeking an active investment approach to the European equity markets. |
| Peculiarities |
| Current Price * | 301.08 EUR | 08.01.2026 |
|---|---|---|
| Previous Price * | 301.49 EUR | 07.01.2026 |
| 52 Week High * | 301.49 EUR | 07.01.2026 |
| 52 Week Low * | 229.61 EUR | 09.04.2025 |
| NAV * | 301.08 EUR | 08.01.2026 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 927,217,857 | |
| Unit/Share Assets *** | 55,750,310 | |
| Trading Information SIX | ||
| YTD Performance | +2.01% |
31.12.2025 - 08.01.2026
31.12.2025 08.01.2026 |
|---|---|---|
| YTD Performance (in CHF) | +1.97% |
31.12.2025 - 08.01.2026
31.12.2025 08.01.2026 |
| 1 month | +4.41% |
08.12.2025 - 08.01.2026
08.12.2025 08.01.2026 |
| 3 months | +6.65% |
08.10.2025 - 08.01.2026
08.10.2025 08.01.2026 |
| 6 months | +11.13% |
08.07.2025 - 08.01.2026
08.07.2025 08.01.2026 |
| 1 year | +20.14% |
08.01.2025 - 08.01.2026
08.01.2025 08.01.2026 |
| 2 years | +32.93% |
08.01.2024 - 08.01.2026
08.01.2024 08.01.2026 |
| 3 years | +41.87% |
09.01.2023 - 08.01.2026
09.01.2023 08.01.2026 |
| 5 years | +55.10% |
08.01.2021 - 08.01.2026
08.01.2021 08.01.2026 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ASML Holding NV | 4.66% | |
|---|---|---|
| Dow Jones Stoxx 400 Retail (5300) | 3.93% | |
| AstraZeneca PLC | 3.61% | |
| Enel SpA | 3.54% | |
| Siemens AG | 3.45% | |
| HSBC Holdings PLC | 3.03% | |
| SAP SE | 3.02% | |
| Sanofi SA | 2.78% | |
| Reckitt Benckiser Group PLC | 2.58% | |
| ING Groep NV | 2.48% | |
| Last data update | 31.10.2025 | |
| TER | |
|---|---|
| TER date | |
| Performance Fee *** | 15.00% |
| PTR | |
| Max. Management Fee *** | 1.80% |
| Ongoing Charges *** | 1.94% |
|
SRRI ***
|
|
| SRRI date *** | 31.12.2025 |